Remove Data Remove Reference Remove Treatment
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Though the Canada-based authors conclude that transdermal delivery of CBD shows great promise and represents a potential novel treatment for chronic inflammatory pain, they also acknowledge that the jury is still out on its ability to achieve that key benchmark of offering tangible clinical benefits. Let us know References: 1.

article thumbnail

Cannabis for Chronic Pain Relief: A New Clinical Framework

The Cannigma

Yet growing evidence suggests that using structured clinical data can help navigate these complexities. Data-driven guidance not only helps mitigate risks but also aligns treatment with the unique physiology and preferences of each patient. Clinical data alone is not enough.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ask The Green Nurse: Puff with Caution: Safer Cannabinoid Options for Asthma Patients

The Cannigma

According to recent data, nearly 79% of cannabis users prefer smoking the plant (National Academies of Sciences, Engineering, and Medicine, 2017). However, further research in humans is necessary to determine if CBD oil is a viable treatment for allergy-induced asthma. Vuolo et al.,

article thumbnail

Ask The Green Nurse: Why Do People Use Medical Cannabis? Top 3 Evidence-Based Reasons to Consider Plant Medicine

The Cannigma

Cannabis is not a universal cure, but for millions, it provides relief when conventional treatments fail. Unlike many conventional treatments, cannabis offers a level of personalization that sets it apart. Beyond the clichés and outdated stereotypes, the real answer lies in the science—and the stories—of healing.

article thumbnail

Study: Adult-Use Legalization Associated with Decline in Youth Treatment Admissions

NORML

The enactment of adult-use cannabis legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions, according to data published in the journal Drug and Alcohol Dependence. Our results indicate that RML in Colorado and Washington was not associated with an increase in treatment admissions.

article thumbnail

This app-guided psychedelic treatment works when antidepressants don’t

The Cannigma

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?